Atropine

Active ingredient description

Atropine is an antimuscarinic agent which competitively antagonises acetylcholine at postganglionic nerve endings, thus affecting receptors if the exocrine glands, smooth muscle, cardiac muscle and the central nervous system.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Atropine
A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03B BELLADONNA AND DERIVATIVES, PLAIN → A03BA Belladonna alkaloids, tertiary amines
Discover more medicines within A03BA01
Atropine
S Sensory organs → S01 Ophthalmologicals → S01F Mydriatics and cycloplegics → S01FA Anticholinergics
Discover more medicines within S01FA01

Medicines

Atropine is the active ingredient of these drugs:

Drug
Countries

Brazil

United States

Brazil

Australia

Hong Kong Singapore

Poland

Brazil

Canada United States

Brazil

Atropine is also found within below combination drugs:

BEAMOTIL , BELLERGOT , CELIDIN , DHAMOTIL , DIAMOTIL , INEUROPE , LOFENOXAL , LOMOTIL , MYDRICAINE , REASEC , SUN-DIANOX , SYNCOMIL

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of product characteristics (SPC)
UK
Summary of product characteristics (SPC)
UK
Structured product labeling (SPL/PLR)
US
Summary of product characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

7C0697DR9I - ATROPINE

CAS registry number

55-48-1 - Atropine

SNOMED-CT

372832002 - Atropine (substance)